Combination budesonide/formoterol inhaler as sole reliever therapy in M āori and Pacific people with mild and moderate asthma.

CONCLUSION: The reduction in severe exacerbation risk with budesonide-formoterol reliever compared with maintenance budesonide was similar in Māori and Pacific adults compared with New Zealand European/Other. PMID: 32994594 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research